A deep pipeline
In just three years, we have developed therapeutic candidates for more than 30 targets in the immune synapse. Our candidates are novel, fully human antibodies – including bispsecifics and multispecifics – and they’re engineered to be readily manufactured at scale.
We’re open to partnerships that will speed development of our therapeutic candidates.
Please contact us at firstname.lastname@example.org.